Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rnav8 Bio
AddedMar 20, 2024
UpdatedJun 18, 2026
Rnav8 Bio

Rnav8 Bio

Seed

RNAV8 Bio engineers large RNAs for treating diseases.

HQ
Laguna Niguel, CA, US
Founded
2022
Overview
Compare
Fundraising
Employees

RNAV8 Bio is a stealth-mode company that focuses on engineering and

designing large RNAs to treat chronic and acute, pre-cancerous diseases.

Rnav8 Bio - Similar Companies

Nextrna Therapeutics logo

Nextrna Therapeutics

Airna logo

Airna

airna.com

Chimeron Bio logo

Chimeron Bio

Rnaimmune logo

Rnaimmune

rnaimmune.com

Locanabio logo

Locanabio

Sanegene Bio logo

Sanegene Bio

sanegenebio.com

Rnaderm Therapeutics logo

Rnaderm Therapeutics

Inceptive logo

Inceptive

inceptive.life

ReNAgade Therapeutics logo

ReNAgade Therapeutics

Silvec Biologics logo

Silvec Biologics

silvec.com

Ochre Bio logo

Ochre Bio

ochre-bio.com

858 Therapeutics logo

858 Therapeutics

8five8tx.com

Laronde logo

Laronde

laronde.bio

Orbital Therapeutics logo

Orbital Therapeutics

Wayfinder Biosciences logo

Wayfinder Biosciences

wayfinderbio.com

Rnav8 Bio - Quick Facts

Who are Rnav8 Bio's competitors?

Companies similar to Rnav8 Bio include Nextrna Therapeutics, Airna, Chimeron Bio and Rnaimmune.

When was Rnav8 Bio founded?

Rnav8 Bio was founded in 2022.

Where is Rnav8 Bio's headquarters located?

Rnav8 Bio's headquarters is located in Laguna Niguel, CA, US.

When was Rnav8 Bio's last funding round?

Rnav8 Bio's most recent funding round was for $599.5k (USD) in December 2022.

How much has Rnav8 Bio raised to-date?

As of Dec 30, 2022, Rnav8 Bio has raised a total of $599.5k (USD).

How many employees does Rnav8 Bio have?

Rnav8 Bio has 5 employees as of Feb 5, 2024.

Rnav8 Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • RNA Treatments
Tags
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified